2006
DOI: 10.1093/bja/ael192
|View full text |Cite
|
Sign up to set email alerts
|

Ketamine and thiopental sodium: individual and combined neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide

Abstract: These data indicate that a low, clinically relevant dose of ketamine offer significant neuroprotection during prolonged exposure to NMDA but not to NOC. Combinations of reduced doses of ketamine and TPS exhibited enhanced neuroprotection against NMDA-induced neurotoxicity. Hence, combinations of these two common i.v. anaesthetics agents could be developed to protect the brain from ischaemia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0
4

Year Published

2010
2010
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(23 citation statements)
references
References 53 publications
0
19
0
4
Order By: Relevance
“…Large doses of KE and rapid intravenous boluses may cause hallucinations, which are less frequent in children than in adults and can be reduced with benzodiazepine premedication [15]. Ketamine has neuroprotective properties by preventing transduction of signals to destructive intracellular mechanisms through the blocking of NMDA receptors [15,16].…”
Section: Discussionmentioning
confidence: 99%
“…Large doses of KE and rapid intravenous boluses may cause hallucinations, which are less frequent in children than in adults and can be reduced with benzodiazepine premedication [15]. Ketamine has neuroprotective properties by preventing transduction of signals to destructive intracellular mechanisms through the blocking of NMDA receptors [15,16].…”
Section: Discussionmentioning
confidence: 99%
“…Thiopental has been known to protect the brain against ischemic damage by attenuation of nitric oxide-induced cytotoxocity26,27 and enhanced glutamate release 28. It has also been shown that thiopental reduces anoxia-mediated Ca 2+ influx in rat hippocampal slices 15.…”
Section: Discussionmentioning
confidence: 99%
“…Many problems still face its clinical Reduced the infarction size [147] Bis (7)tacrine Showed neuroprotective effect against retinal ischemic damage [148] Cerestat Had a good preclinical profile, but low clinical efficacy [149] Dextromethorphan It reduced infarction size but with a variety of dose-related reversible adverse events [150] Dizocilpine Reduced the infarction volume, but most effective given early after ischemia with neuropsychiatric problems [151] Gavestinel Generally better tolerated without neuropsychiatric adverse effects but it had little effects of on infarct volume in patients with ischemic stroke [152] Ketamine and thiopental Showed neuroprotective effects against NMDA-induced neurotoxicity [153] Magnesium Beside NMDAR blocking, it inhibited excitatory neurotransmitter release, blocked Ca 2? channels, dilated the cerebral vasculature [154] Memantine Improved neurochemical and neurobehavioral functions after ischemia [155] Dizocilpine Reduced the infarction size [156] Remacemide Reduced the infarction size [157] Traxoprodil Modest neuroprotective activity in humans with stroke [158] AMPAR blockers NBQX Had neuroprotective capacities but was associated with nephrotoxicity [159] PNQX Showed neuroprotective effects against oxygen-glucose deprivation [160] KAR blockers Inhibition of postreceptor signaling mechanisms Lubeluzole It inhibited glutamate-induced activation of NOS reducing infarction volume in experimental animals [167] PSD-95 inhibitors, e.g., N-alkylated tetrapeptides Reduced infarction size even after ischemic insult and improve neurobehavioral changes [168] Inhibitors of Ca 2?…”
Section: Drugs Inhibiting Glutamate-induced Cell Injurymentioning
confidence: 99%